Xtant Medical Holdings Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Xtant Medical Holdings

Access the complete profile.

Xtant Medical Holdings Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	339113 Surgical Appliance & Supplies Manufacturing 54133 Engineering Services
Address	664, Cruiser Lane Belgrade, MT 59714

Note: Revenues for privately held companies are statistical evaluations.


Xtant Medical Holdings's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Xtant Medical Holdings's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Xtant Medical Holdings is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Xtant Medical Holdings Annual Revenue and Growth Rate

Xtant Medical Holdings	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Xtant Medical Holdings's revenues are gauged from an analysis of company filings.

Xtant Medical Holdings's Income Statement (based on Industry Averages)

Xtant Medical Holdings P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Xtant Medical Holdings is developing and marketing. Xtant Medical Holdings's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
SIMPLICHOR Biological tissue grafts, namely, amniotic membrane grafts; biological tissue grafts; biological tissue grafts, namely, chorionic membrane grafts	06/21/2023
SIMPLIGRAFT Biological tissue grafts, namely, amniotic membrane grafts; biological tissue grafts	04/11/2023
CORTERA Surgical implants comprising artificial material and associated surgical instrument sets	02/18/2022

See all trademarks and details in the Full Report.

Market Share of Xtant Medical Holdings's Largest Competitors

A competitive analysis shows these companies are in the same general field as Xtant Medical Holdings, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Xtant Medical Holdings. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BACTERIN INTERNATIONAL	Belgrade, MT	100
XTANT MEDICAL HOLDINGS	Belgrade, MT	71
SUSTAINABLE BIOPRODUCTS	Bozeman, MT	34
BLACKMORE SENSORS & ANALYTICS	Bozeman, MT	31
MONTANA INSTRUMENTS	Bozeman, MT	22
BRIDGER PHOTONICS	Bozeman, MT	18

Future Competition: Xtant Medical Holdings's Fastest Growing Competitors

These companies are in the same general field as Xtant Medical Holdings and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)